πŸ‡ΊπŸ‡Έ FDA
Patent

US 9474830

PEGylated fibrinogen precursor molecule

granted A61KA61K38/363A61K38/39

Quick answer

US patent 9474830 (PEGylated fibrinogen precursor molecule) held by REGENTIS BIOMATERIALS LTD. expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENTIS BIOMATERIALS LTD.
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/363, A61K38/39, A61K38/45, A61K47/60